The FOURIER trial was set up to study the clinical outcomes of evolocumab in patients with hypercholesterolemia and a history of cardiovascular disease that use statins. Diabetes mellitus was an… Click to show full abstract
The FOURIER trial was set up to study the clinical outcomes of evolocumab in patients with hypercholesterolemia and a history of cardiovascular disease that use statins. Diabetes mellitus was an outcome of particular interest, because it is a known serious adverse effect of statins [1]. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.